RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Dynavax Technologies Stock

Dynavax Technologies Debt 2024

Dynavax Technologies Debt

72.42 USD

Ticker

DVAX

ISIN

US2681582019

WKN

A12EV9

In 2024, Dynavax Technologies's total debt was 72.42 USD, a 269.48% change from the 19.6 USD total debt recorded in the previous year.

Dynavax Technologies Aktienanalyse

What does Dynavax Technologies do?

Dynavax Technologies Corp is a US-based biotechnology company that specializes in developing innovative therapies and vaccines to combat infectious diseases and cancer. The company was founded in 1996 and is headquartered in Emeryville, California. Dynavax's roots can be traced back to the research work of Dr. Lawrence Steinman, a renowned immunologist at Stanford University. The company initially focused on researching autoimmune diseases such as multiple sclerosis and arthritis. In 2001, Dynavax received approval from the US Food and Drug Administration (FDA) for their first developed product called HEPLISAV, a hepatitis B vaccine. The company's business model is based on researching and developing therapies and vaccines based on immunology and genetics. Dynavax conducts intensive research in its laboratories to develop new treatment approaches and vaccines. The company collaborates closely with universities, government institutions, and other biotechnology companies to test and verify the effectiveness and safety of its products. Dynavax is divided into several divisions to oversee its product development and distribution activities. These divisions include vaccines, oncology, and autoimmune diseases. Dynavax has introduced several products to the market in recent years, including HEPLISAV, SD-101, AZD1419, and DYVAX FQ. The company continues to focus on researching and developing new therapies and vaccines. Dynavax Technologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Dynavax Technologies's Debt Structure

Dynavax Technologies's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Dynavax Technologies's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Dynavax Technologies’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Dynavax Technologies’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Dynavax Technologies stock

What is the debt of Dynavax Technologies this year?

Dynavax Technologies has a debt level of 72.42 USD this year.

What was the debt of Dynavax Technologies compared to the previous year?

The debt of Dynavax Technologies has increased by 269.48% compared to the previous year increased.

What are the consequences of high debt for investors in Dynavax Technologies?

High debt can pose a risk for investors of Dynavax Technologies, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Dynavax Technologies?

Low debt means that Dynavax Technologies has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Dynavax Technologies affect the company?

An increase in debt of Dynavax Technologies can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Dynavax Technologies affect the company?

A reduction in debt of Dynavax Technologies can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Dynavax Technologies?

Some factors that can influence the debt of Dynavax Technologies include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Dynavax Technologies so important for investors?

The debts of Dynavax Technologies are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Dynavax Technologies take to change the debt?

To change the debt, Dynavax Technologies can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Dynavax Technologies pay?

Over the past 12 months, Dynavax Technologies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Dynavax Technologies is expected to pay a dividend of 0 USD.

What is the dividend yield of Dynavax Technologies?

The current dividend yield of Dynavax Technologies is .

When does Dynavax Technologies pay dividends?

Dynavax Technologies pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Dynavax Technologies?

Dynavax Technologies paid dividends every year for the past 0 years.

What is the dividend of Dynavax Technologies?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Dynavax Technologies located?

Dynavax Technologies is assigned to the 'Health' sector.

Wann musste ich die Aktien von Dynavax Technologies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Dynavax Technologies from 12/12/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/12/2024.

When did Dynavax Technologies pay the last dividend?

The last dividend was paid out on 12/12/2024.

What was the dividend of Dynavax Technologies in the year 2023?

In the year 2023, Dynavax Technologies distributed 0 USD as dividends.

In which currency does Dynavax Technologies pay out the dividend?

The dividends of Dynavax Technologies are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Dynavax Technologies

Our stock analysis for Dynavax Technologies Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Dynavax Technologies Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.